PharmaCyte Biotech, Inc. (NASDAQ:PMCB) Short Interest Update
PharmaCyte Biotech, Inc. (NASDAQ:PMCB – Get Free Report) was the target of a significant decrease in short interest in the month of October. As of October 31st, there was short interest totalling 33,300 shares, a decrease of 17.4% from the October 15th total of 40,300 shares. Based on an average trading volume of 20,600 shares, […]
More Stories
What is Zacks Research’s Forecast for IRWD Q2 Earnings?
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Analysts at Zacks Research upped their Q2 2025 EPS estimates for Ironwood...
B. Riley Equities Analysts Reduce Earnings Estimates for HCC
Warrior Met Coal, Inc. (NYSE:HCC – Free Report) – Investment analysts at B. Riley dropped their Q2 2025 earnings per...
What is DA Davidson’s Forecast for Kadant Q2 Earnings?
Kadant Inc. (NYSE:KAI – Free Report) – Equities researchers at DA Davidson issued their Q2 2025 earnings per share estimates...
Telsey Advisory Group Has Negative View of HVT Q2 Earnings
Haverty Furniture Companies, Inc. (NYSE:HVT – Free Report) – Research analysts at Telsey Advisory Group reduced their Q2 2025 EPS...
Q2 EPS Estimate for Larimar Therapeutics Raised by Analyst
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) – Analysts at William Blair boosted their Q2 2025 earnings per share estimates...
Q2 EPS Estimates for Mastercard Boosted by Seaport Res Ptn
Mastercard Incorporated (NYSE:MA – Free Report) – Research analysts at Seaport Res Ptn raised their Q2 2025 earnings estimates for...